Clinical trial · Observational
The Possible Influence of Different Follow-up Modalities on Overall Survival in Ovarian Cancer
The Possible Influence of Different Follow-up Modalities on Overall Survival in Ovarian Cancer: A Multicenter Observational Cohort Study
NCT05352217CI-TRIAL-00076328ECOvarterminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Accrual rate fell far below needed accrual rate.
Summary
Brief summary (as posted)
The study is designed as an observational cohort study, aiming to evaluate, whether a structured recording of symptoms by a mobile app contributes insight in the follow-up modalities of ovarian cancer patients.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Neoplasms | Ovarian Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Patient Reported Outcome Measures | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mobile app ovarian cancer followup (ePRO) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Overall survival three years after end of therapy
- timeFrame
- 3 years
- description
- Overall survival three years after the end of primary therapy / start of follow-up
Secondary outcomes (7)
- measure
- Time to Recurrence
- timeFrame
- 3 years
- description
- Time to Recurrence
- measure
- Total number of tumor relapses
- timeFrame
- 3 years
- description
- Total number of tumor relapses occurring in the follow-up period
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Women aged ≥ 18 years * Between diagnosis and the first follow-up visit after the end of their antineoplastic treatment (systemic therapy or surgical treatment) for ovarian cancer. * German, English, French, or Italian speaking * Personal smartphone (iOS or Android system); one of the latest three main versions Exclusion Criteria: • Patients whose compliance must be questioned, e.g. due to a psychiatric disorder, private life situation or insufficient knowledge on smartphone use and do not have a suitable caregiver to assist them with symptom reporting.
References
Publications (0)
Data not yet available
No reference posted for this study.